New cancer treatment approved in Australia
        
        
        
        
          
          
          
          
        
      
        
    
        
        (19 Dec 18) Novartis Australia has announced the TGA approval of Kymriah® (tisagenlecleucel), for the…
        
        
        Dr Dawn Driscoll appointed as CEO at Cell Therapies Pty Ltd
        
        
        
        
          
          
          
          
        
        
      
        
    
        
        Cell Therapies Pty Ltd is delighted to announce the appointment of Dr Dawn Driscoll as…
Cell TherapiesOctober 4, 2017
        
        CTPL awarded Australian Global Innovation Linkages programme grant
        
        
        
        
          
          
          
          
        
        
      
        
    
        
        Melbourne, Australia 26 June 2017: Cell Therapies has been awarded $1,000,000 in funding by the…
Cell TherapiesJune 26, 2017
        
        CTPL receives APAC Bioprocessing Excellence Award
        
        
        
        
          
          
          
          
        
        
      
        
    
        
        Melbourne, Australia 20 February 2017: Cell Therapies commitment to, and excellence in, bringing innovative cellular…
Cell TherapiesFebruary 20, 2017
        
        CTPL CEO, Tim Oldham, elected to Alliance for Regenerative Medicine 2017 Board of Directors
        
        
        
        
          
          
          
          
        
        
      
        
    
        
        Melbourne, Australia, 11 October 2016: Cell Therapies Pty Ltd (CTPL) is pleased to announce that…
Cell TherapiesOctober 26, 2016
        
        ISCT 2016
        
        
        
        
          
          
          
          
        
        
      
        
    
        
        CT's contribution to ISCT 2016 Representatives from Cell Therapies presented at ISCT Singapore on the…
Cell TherapiesAugust 19, 2016
        
        Apheresis for cellular therapy manufacturing: need for improved collection data
        
        
        
        
          
          
          
          
        
        
      
        
    
        
        Melbourne 8 Feb 2016: Cell collection via apheresis is the starting point for manufacture of…
Cell TherapiesFebruary 8, 2016
        
        Reform Needed To Fulfill Our Biotech Potential
        
        
        
        
          
          
          
          
        
        
      
        
    
        
        REFORM NEEDED TO FULFILL OUR BIOTECH POTENTIAL is an article by AusBiotech’s Chief Executive, Dr…
Cell TherapiesOctober 7, 2015
        
        Confirmation of BioNexus Award to CTPL
        
                
        
          
          
          
          
        
        
      
        
    Melbourne and Kuala Lumpur 30 Sep 2015: Cell Therapies Pty Ltd (CTPL) has today received…
Cell TherapiesOctober 5, 2015
        
        CTPL CSO Dominic Wall comments on opportunities and challenges of CAR-T therapy in lead-up to AusBiotech 2015
        
                
        
          
          
          
          
        
        
      
        
    Cell Therapies’ Chief Scientific Officer, Dr Dominic Wall will participate in AusBiotech2015 as part of…
Cell TherapiesSeptember 25, 2015
        
        CTPL featured in Australasian Biotechnology Advanced Manufacturing Feature
        
                
        
          
          
          
          
        
        
      
        
    Cell Therapies Pty Ltd has been profiled in Australian Biotechnology’s most recent edition featuring advanced…
Cell TherapiesSeptember 22, 2015